Literature DB >> 9137092

Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.

T Couffinhal1, M Kearney, B Witzenbichler, D Chen, T Murohara, D W Losordo, J Symes, J M Isner.   

Abstract

Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) is an endothelial-cell-specific mitogen; as such, its role in angiogenesis has been studied extensively. VEGF/VPF may also serve as a local, endogenous regulator of large-vessel endothelial cell integrity. Surprisingly, however, VEGF/VPF expression in normal and/or atherosclerotic vessels has not been previously characterized. Accordingly, we studied normal human arteries and veins as well as atherosclerotic and restenotic human coronary arteries for evidence of VEGF/VPF expression. VEGF/VPF was detected immunohistochemically in sections of normal human aorta, mammary artery, and saphenous vein. Moreover, VEGF/ VPF expression was identified in 32 (97%) of 33 pathological coronary arterial specimens; the extent of VEGF/VPF staining was graded as moderate to strong in 21 of the 32 (66%) positive specimens. VEGF/VPF double immunostaining and in situ hybridization demonstrated that smooth muscle cells constitute the principal cellular source of VEGF/VPF. VEGF/VPF immunostaining among primary atherosclerotic lesions localized predominantly to the extracellular matrix. In restenotic specimens, VEGF/VPF immunostaining was more prominently cellular, particularly among proliferating smooth muscle cells. Although VEGF/VPF expression was observed in areas of macrophage infiltration, double immunostaining failed to localize VEGF/VPF to macrophages in these foci; instead, double immunostaining clearly identified CD45RO-positive cells as responsible for VEGF/VPF expression in such areas. No correlation could be demonstrated between VEGF/VPF immunostaining and extent of vasa vasorum. These findings thus establish that postnatal VEGF/VPF expression is a feature of normal human arteries and veins and is often extensively expressed in arteries narrowed by atherosclerotic plaque. VEGF/VPF expression in the wall and/or plaque of medium to large vessels suggests a role for VEGF/VPF other than promoting angiogenesis. This role may involve maintenance and repair of luminal endothelium.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9137092      PMCID: PMC1858200     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues.

Authors:  L B Jakeman; J Winer; G L Bennett; C A Altar; N Ferrara
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

2.  American College of Cardiology 45th Annual Scientific Session, Orlando, Florida, March 24 to 27, 1996.

Authors:  J J Ferguson
Journal:  Circulation       Date:  1996-07-01       Impact factor: 29.690

3.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

4.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues.

Authors:  W T Monacci; M J Merrill; E H Oldfield
Journal:  Am J Physiol       Date:  1993-04

Review 6.  Endothelial dysfunction in coronary artery disease.

Authors:  T F Lüscher; F C Tanner; M R Tschudi; G Noll
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

7.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

Authors:  D Shweiki; A Itin; D Soffer; E Keshet
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

8.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

Authors:  K H Plate; G Breier; H A Weich; W Risau
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

9.  Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Authors:  P Carmeliet; V Ferreira; G Breier; S Pollefeyt; L Kieckens; M Gertsenstein; M Fahrig; A Vandenhoeck; K Harpal; C Eberhardt; C Declercq; J Pawling; L Moons; D Collen; W Risau; A Nagy
Journal:  Nature       Date:  1996-04-04       Impact factor: 49.962

10.  Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation.

Authors:  G Breier; U Albrecht; S Sterrer; W Risau
Journal:  Development       Date:  1992-02       Impact factor: 6.868

View more
  35 in total

1.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 2.  Association of anticardiolipin antibodies with vascular injury: possible mechanisms.

Authors:  Y S Haviv
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Dynamics of vascular growth factors after coronary angioplasty.

Authors:  Iu I Buziashvili; S T Matskeplishvili; D Kh Kamardinov; A V Staferov; M A El'darov; K G Skryabin; M P Kirpichnikov; L A Bokeriia; R V Petrov
Journal:  Dokl Biol Sci       Date:  2004 Jul-Aug

4.  Vascular endothelial growth factor localization in the adult.

Authors:  Arindel S R Maharaj; Magali Saint-Geniez; Angel E Maldonado; Patricia A D'Amore
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  PF-2341066 combined with celecoxib promotes apoptosis and inhibits proliferation in human cholangiocarcinoma QBC939 cells.

Authors:  Chen Chen; Dinghua Yang; Qinghua Zeng; Liang Luo; Chengzhi Cai
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

Review 6.  Regulation of microvascular permeability by vascular endothelial growth factors.

Authors:  D O Bates; N J Hillman; B Williams; C R Neal; T M Pocock
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

Review 7.  Vascular endothelial growth factor control mechanisms in skeletal growth and repair.

Authors:  Kai Hu; Bjorn R Olsen
Journal:  Dev Dyn       Date:  2016-12-29       Impact factor: 3.780

8.  Mouse model of angiogenesis.

Authors:  T Couffinhal; M Silver; L P Zheng; M Kearney; B Witzenbichler; J M Isner
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease.

Authors:  Mehmet Akif Oztürk; Selman Unverdi; Suna O Oktar; Neslihan Bukan; Ozlem Gülbahar; Kemal Ureten; Berna Göker; Seminur Haznedaroglu; Gülten Sungur; Tansu Ulukavak Ciftçi; A Mesut Onat
Journal:  Clin Rheumatol       Date:  2008-01-18       Impact factor: 2.980

10.  Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia.

Authors:  B Witzenbichler; T Asahara; T Murohara; M Silver; I Spyridopoulos; M Magner; N Principe; M Kearney; J S Hu; J M Isner
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.